Zacks Research Estimates Palomar’s Q1 Earnings (NASDAQ:PLMR)

Palomar Holdings, Inc. (NASDAQ:PLMR) – Equities researchers at Zacks Research upped their Q1 2026 earnings per share estimates for shares of Palomar in a research report issued on Tuesday, February 24th. Zacks Research analyst Team now forecasts that the company will earn $2.07 per share for the quarter, up from their prior estimate of $1.89. The consensus estimate for Palomar’s current full-year earnings is $5.99 per share. Zacks Research also issued estimates for Palomar’s Q2 2026 earnings at $1.95 EPS, Q3 2026 earnings at $2.67 EPS, Q4 2026 earnings at $2.30 EPS, FY2026 earnings at $9.00 EPS, Q1 2027 earnings at $2.46 EPS, Q2 2027 earnings at $2.30 EPS, Q3 2027 earnings at $2.82 EPS, FY2027 earnings at $9.60 EPS and FY2028 earnings at $12.60 EPS.

Palomar (NASDAQ:PLMR) last posted its earnings results on Wednesday, February 11th. The company reported $2.24 EPS for the quarter, beating analysts’ consensus estimates of $2.06 by $0.18. Palomar had a net margin of 22.50% and a return on equity of 22.77%. The company had revenue of $253.36 million for the quarter, compared to analysts’ expectations of $204.58 million. During the same quarter in the prior year, the company posted $1.52 earnings per share. Palomar’s revenue for the quarter was up 62.7% compared to the same quarter last year.

Other analysts also recently issued research reports about the stock. JPMorgan Chase & Co. lifted their target price on shares of Palomar from $155.00 to $160.00 and gave the company an “overweight” rating in a report on Monday, February 23rd. Wall Street Zen raised Palomar from a “hold” rating to a “buy” rating in a research note on Saturday, February 21st. Keefe, Bruyette & Woods boosted their price objective on Palomar from $170.00 to $171.00 and gave the company an “outperform” rating in a report on Tuesday, January 6th. Evercore initiated coverage on Palomar in a report on Monday, February 9th. They set an “outperform” rating and a $150.00 target price for the company. Finally, Weiss Ratings raised Palomar from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, January 14th. Seven analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company has an average rating of “Buy” and an average price target of $163.00.

Palomar Stock Performance

Palomar stock opened at $123.71 on Friday. The company’s 50 day simple moving average is $128.55 and its 200-day simple moving average is $123.20. Palomar has a 1 year low of $107.75 and a 1 year high of $175.85. The company has a market capitalization of $3.30 billion, a price-to-earnings ratio of 17.23 and a beta of 0.44.

Insider Buying and Selling

In related news, insider Angela L. Grant sold 260 shares of Palomar stock in a transaction that occurred on Saturday, January 31st. The shares were sold at an average price of $121.75, for a total value of $31,655.00. Following the completion of the transaction, the insider owned 7,033 shares in the company, valued at $856,267.75. The trade was a 3.57% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, President Jon Christianson sold 522 shares of the business’s stock in a transaction that occurred on Wednesday, February 18th. The stock was sold at an average price of $128.04, for a total transaction of $66,836.88. Following the transaction, the president owned 65,919 shares of the company’s stock, valued at $8,440,268.76. This trade represents a 0.79% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 58,999 shares of company stock worth $7,253,229 over the last ninety days. Company insiders own 3.70% of the company’s stock.

Institutional Investors Weigh In On Palomar

Several institutional investors have recently modified their holdings of PLMR. Janus Henderson Group PLC increased its holdings in Palomar by 250.1% in the fourth quarter. Janus Henderson Group PLC now owns 795,625 shares of the company’s stock valued at $107,237,000 after buying an additional 568,360 shares during the last quarter. Invesco Ltd. boosted its position in shares of Palomar by 234.1% during the 2nd quarter. Invesco Ltd. now owns 798,361 shares of the company’s stock worth $123,147,000 after acquiring an additional 559,383 shares in the last quarter. Alliancebernstein L.P. boosted its position in shares of Palomar by 290.2% during the 2nd quarter. Alliancebernstein L.P. now owns 497,080 shares of the company’s stock worth $76,675,000 after acquiring an additional 369,697 shares in the last quarter. Westfield Capital Management Co. LP increased its holdings in shares of Palomar by 81.0% in the 3rd quarter. Westfield Capital Management Co. LP now owns 738,528 shares of the company’s stock valued at $86,223,000 after acquiring an additional 330,592 shares during the last quarter. Finally, Sumitomo Mitsui Trust Group Inc. raised its position in shares of Palomar by 72.1% during the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 785,165 shares of the company’s stock worth $105,809,000 after acquiring an additional 328,993 shares in the last quarter. 90.25% of the stock is owned by hedge funds and other institutional investors.

Key Palomar News

Here are the key news stories impacting Palomar this week:

• Positive Sentiment: Zacks Research raised FY2026 EPS to $9.00 (from $8.00) and boosted FY2027 to $9.60 and FY2028 to $12.60 — a sizeable multi‑year upgrade that implies stronger forward profitability. MarketBeat PLMR
• Positive Sentiment: Zacks lifted several near‑term quarterly estimates: Q1 2026 to $2.07 (from $1.89), Q2 2026 to $1.95 (from $1.87), and Q3 2026 to $2.67 (from $1.91). They also raised Q1–Q3 2027 quarterlies (Q1 2027 to $2.46, Q2 2027 to $2.30, Q3 2027 to $2.82), reflecting a consistent upward revision pattern. MarketBeat PLMR
• Neutral Sentiment: A Zacks feature summarizing Street views notes the average analyst price target implies roughly 36.2% upside for PLMR — a bullish signal for sentiment but not a guarantee of price moves. Wall Street Analysts Think Palomar Could Surge
• Negative Sentiment: Zacks trimmed its Q4 2026 estimate slightly to $2.30 from $2.34 — a modest downgrade that appears isolated versus broad upward revisions elsewhere. MarketBeat PLMR

Palomar Company Profile

Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.

In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.